Jayson Rieger

CEO and President

Jayson Rieger (CEO and President) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in VRCA. Across 1 priced purchase filing, the average 21-session return was +73.2% from execution and +73.2% from disclosure (delay-adjusted; derived). The largest single filing was $400K of VRCA (94,311 sh × $4.24, as filed), executed Nov 25 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+73.2%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+73.2%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$400K

shares × price, as filed

Last traded

Nov 25 2025

Filed Nov 25 2025

Open performance→

Volume by month

Buys $3.2M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names

VRCA VRCA VRCA · 2 buys · 0 sells 2 filings

Recent filings

VRCAPURCHASE Verrica Pharmaceuticals Inc. View filing → $400K
94,311 sh × $4.24
Exec Nov 25 2025
Filed Nov 25 2025 · 7:00 PM ET VRCAPURCHASE Verrica Pharmaceuticals Inc. View filing → $2.8M
as filed
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET